期刊名称：CANCER SCIENCE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Cancer Science |
|
The Official Journal of the Japanese Cancer Association
Edited by:
Takashi Tsuruo
Print ISSN: 1347-9032
Online ISSN: 1349-7006
Frequency: Monthly
Current Volume: 96
ISI Journal Citation Reports Ranking:
Impact Factor: 1.624 |
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, today the Journal continues to publish original articles and editorials, letters to the editor, and reports describing original research in the fields of basic, translational and clinical cancer. Review articles may also be published.
Subject categories include; carcinogenesis, tumor biology and pathology, molecular biology and genetics, epidemiology and prevention, immunology and virology, experimental therapeutics and clinical medicine.
Instructions to Authors
Author Guidelines |
|
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Authors may present names of potential referees and of referees whom they would prefer not to review the manuscript. The choice of reviewers remains the Editor¡¯s prerogative.
A manuscript requiring revision will be returned to the author by email, along with specific suggestions for revision. The author should reply to these suggestions clearly by indicating places where revisions have been made, and/or by stating reasons for disregarding other suggestions if they are thought to be unacceptable. The revised manuscript should then be resubmitted (two copies and a disk in the case of manuscripts on paper). Revised manuscripts should be returned to the Editorial Office within 1 month (minor revision) or 3 months (rejected but encouraged for resubmission); otherwise they are considered to be new submissions and will be assigned a new date of receipt.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
SUBMISSION OF MANUSCRIPTS
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
Manuscripts can be submitted via email to cancerscience@blackwellpublishingasia.com. Authors must supply an email address as all correspondence will be by email. Two files should be supplied: the covering letter and the manuscript (in Word or rich text format (.rtf). Please refer to the section ¡®MANUSCRIPTS ON DISK OR EMAIL¡¯ for guidelines regarding electronic submission.
For a limited time, hard copy submissions will continue to be accepted. The original manuscript and four copies along with a floppy disk containing the text files should be submitted to:
Editorial Office of Cancer Science
c/o Blackwell Publishing Asia
GS Chiyoda Bldg.
5F 3-11-14 Iidabashi
Chiyoda-ku
Tokyo 102-0072
Japan
Submissions should be printed, double-spaced, on one side only of ISO A4 paper. The top, bottom and side margins should be at least 30 mm. Laser quality print is essential. All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
Covering letter
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.
The covering letter should the following information:
That the paper is being submitted for consideration for publication in Cancer Science
Contact details at which the corresponding author can be contacted, including mailing address, telephone and FAX numbers and an email address;
Acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author¡¯s contribution to the paper is to be quantified;
A declaration of any financial support or relationships that may pose conflict of interest;
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter;
The salient and novel findings of the paper in a concise paragraph;
The subject category that applies to the manuscripts (please choose one only): Carcinogenesis; Tumor Biology and Pathology; Molecular Biology and Genetics; Epidemiology and Prevention; Immunology and Virology; Experimental Therapeutics and Clinical Medicine.
Submitted manuscripts should be accompanied by a disk containing the covering letter, text (preferably in Microsoft word), and figures. The computer used, the OS and word processing software should be indicated on the label.
A signed Copyright Assignment Form.
Author material archive policy
Authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Blackwell Publishing will dispose of all hardcopy and electronic material two months after publication.
ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000), available at http://www.wma.net/e/policy/b3.htm.
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
COPYRIGHT
Papers accepted for publication become copyright of the Japanese Cancer Association and authors will be asked to sign a transfer of copyright form. In signing the transfer of copyright it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the Copyright Assignment Form, and must sign the Form or agree that the corresponding author can sign on their behalf. Articles cannot be published until a signed Copyright Assignment Form has been received.
STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors¡¯ revised ¡®Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication¡¯, as presented at http://www.ICMJE.org/.
Spelling. The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam¨CWebster¡¯s Collegiate Dictionary.
Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
Abbreviations. Abbreviations used should be consistent with recommended international nomenclature. If there are few abbreviations used, initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only. If there are many non-standard abbreviations, they should be listed in a footnote.
Nomenclature. Names of chemical compounds should conform to the International Union for Pure and Applied Chemistry (IUPAC) nomenclature and biochemical terms to those of the International Union of Biochemistry (IUB). Chemical substances should be referred to by the generic name only. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses. Names of enzymes should conform to the nomenclature recommended by IUB, the name to be followed by the enzyme number (EC) in parentheses.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ¡®These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.¡¯
Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
GenBank http://www.ncbi.nlm.nih.gov
PARTS OF THE MANUSCRIPT
The length of an Original Article (including references, tables and appendices) should not exceed 8 double-spaced, printed pages, including figures and tables. Review Articles should be no longer than 16-20 pages, with no more than 50 references (4000¨C5000 words), together with 4¨C6 figures and/or tables, which will be approximately 4-6 printed pages.
Manuscripts should be presented in the following order: (i) title page, (ii) summary, key words and abbreviations, (iii) text (including Introduction, Materials and Methods, Results, Discussion) (iv) acknowledgments, (v) references, (vi) appendices, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page
The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short (preferably less than 120 letters), informative and contain the major key words. Do not use unnecessary words such as ¡®Study of¡¯ or ¡°Results on¡±, or abbreviations in the title. A short running title (less than 40 characters) should also be provided.
Summary
All articles must have a summary that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Species, strain and sex of animals used should be indicated. The abstract should not contain abbreviations or references.
Text
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Materials and Methods, Results and Discussion.
Introduction. The introduction should mention the purpose of the investigation, its relation to other work in the field, and the reasons for undertaking the research. Brief reference to the most relevant papers is sufficient.
Materials and Methods. Description of methods should be brief, but with sufficient detail to enable others to reproduce the experiments. When published procedures are used, the appropriate references should be cited. Only new and significant modifications of previously published procedures require complete description. Names of products and manufacturers with their locations (city and state/country) should be given and sources of animals and tumors should always be indicated.
Results. The results should be described concisely. Tables and figures should be used only if they are indispensable for the comprehension of data.
Discussion. The results should be interpreted and related to existing knowledge in the field. Information already given in the introduction or results should not be repeated.
Acknowledgments
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors¡¯ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
References
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated in the style used in Index Medicus.
Authors are responsible for the accuracy of the references.
Journal article
1 Chenevix-Trench G, Spurdle AB, Gatei M et al. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 2002; 94: 205-15.
Book
2 Ringsven MK, Bond D. Gerontology and Leadership Skills for Nurses, 2nd edn. Albany, NY: Delmar Publishers, 1996.
Chapter in a Book
3 Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995; 465¨C78.
Published on the World Wide Web
4 Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis (Serial online) 1995 Jan¨CMar; 1(1): (24 screens). [Cited 5 Jun 1996.] Available from URL: www.xxx.com
If the title of a paper is in English, French of German, it should be written in the original language. The present policy of Cancer Science is to reduce to a minimum citation of works which are not widely available to the international scientific community. However, if the title of an essential citation is in another language, such as Japanese or Russian, it should be translated into English, and the original language should be indicated in parentheses.
Appendices
These should be placed at the end of the paper, numbered in Roman numerals and referred to in the text. If written by a person other than the author of the main text, the writer¡¯s name should be included below the title.
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate sheet with the legend above. Legends should be concise but comprehensive ¨C the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: ??, ??, ¡ì, ??, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. Tables should be submitted in Microsoft word or excel. Image date should be avoided.
Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Each figure should be labeled on the back in very soft marker or chinagraph pencil, indicating name of author(s), figure number and orientation. Do not use adhesive labels as this prohibits electronic scanning. Figures should be sized to fit within the column (88 mm), intermediate (114 mm) or the full text width (180 mm). Materials of inappropriate size will be reduced by the Editorial Office.
Line figures should be supplied as sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package. Lettering must be included and should be sized to be no larger than the journal text. Photographs should be supplied as sharp, glossy, black-and-white or color photographic prints and must be unmounted. Individual photographs forming a composite figure should be of equal contrast, to facilitate printing, and should be accurately squared. If color reproduction of figures is preferred, submit the original color figure and three sets of color copies. The Editorial Office will decide if color printing is warranted, and if so a fee will be charged to the author.
Magnifications should be indicated using a scale bar on the illustration.
If supplied electronically, graphics must be supplied as high resolution (at least 600 d.p.i.) files, saved as .eps or .tif. A high-resolution print-out must also be provided. Digital images supplied only as low-resolution print-outs and/or files cannot be used.
Figure legends. Type figure legends on a separate sheet. Legends should be concise but comprehensive ¨C the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
MANUSCRIPTS ON DISK OR EMAIL
Authors are required to provide electronic copies of their manuscripts, to be submitted either via email or on disk. It is essential that the paper version of the manuscript and the electronic file are identical.
The following instructions should be adhered to:
?? If submitting on disk, use a new disk rather than a reformatted disk.
?? The disk must contain the relevant file(s) only. The entire article (including tables) should be supplied as a single file; only electronic figures should be supplied as separate files.
?? Authors should supply their paper as formatted text. Specify the hardware and the word processing package on the disk (e.g. IBM, Word 2000 or Mac, Word 5.1), as well as the first author¡¯s surname, the journal title and the manuscript number.
?? Do not use the carriage return (Enter) at the end of lines within a paragraph.
?? Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
?? Specify any special characters used to represent non-keyboard characters.
?? Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ?? (German esszett) for ?? (Greek beta).
?? Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
?? Figures should be supplied as separate files, with the figure number incorporated in the file name. For submission, figures saved as .jpg or .pdf files will be accepted, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 600 d.p.i.) saved as .eps or .tif files should be provided. Digital images supplied only as low-resolution files cannot be used.
PROOFS
It is essential that corresponding authors supply an email address to which proofs can be emailed. A Portable Document Format (PDF) typeset proof will be sent via email as a final check of the layout, tables and figures. Alterations (other than the essential correction of errors) are unacceptable at PDF stage. Further instructions will be sent with the proof. Authors will be given a 48 hour turn-around time to return proof corrections. Authors who will not be available to check their proofs should appoint someone to proofread their article. If the proof is not returned by the appointed date, it may be signed off on by the Editor or held over to the next issue.
OFFPRINTS
A minimum of 50 offprints will be provided upon request, at the author¡¯s expense. An Offprint Order Form will be sent to the corresponding author with the PDF proof. Offprints will be provided only if a completed Offprint Order Form is returned to the Publisher by the specified date.
PUBLICATION FEES
A charge of US$700/??80 000 for the first three color figures with US$350/??40 000 for each extra color figure thereafter will be charged to the author.
Authors are required to pay a page charge of US$50/??5 000 per printed page. Solicited articles are published free of charge.
ONLINE EARLY
Cancer Science is covered by Blackwell Publishing¡¯s OnlineEarly service. OnlineEarly articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. OnlineEarly articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors¡¯ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of OnlineEarly articles means that they do not yet have volume, issue or page numbers, so OnlineEarly articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.
BLACKWELL JOURNALS ONLINE
Visit the Cancer Science home page at http://www.blackwellpublishing.com/cas for more information, and Blackwell Publishing¡¯s web pages for submission guidelines and digital graphics standards at http://www.blackwellpublishing.com/authors/journal.asp and http://www.blackwellpublishing.com/authors/digill.asp. Cancer Science is also available online via Blackwell Synergy at http://www.blackwell-synergy.com.
|
Editorial Board
Editor-in-Chief
Takashi Tsuruo, The University of Tokyo
Editors
Setsuo Hirohashi, National Cancer Center
Yusuke Nakamura, The University of Tokyo
Ryuzo Ueda, Nagoya City University
Editor for Review Articles
Toshitada Takahashi, Aichi Cancer Center
Editor Emeritus
Takashi Sugimura
Associate Editors
Shin-ichi Akiyama, Kyu-Won Kim, Masao Seto, Tetsu Akiyama, Yukihiko Kitamura, Masabumi Shibuya, Hirofumi Arakawa, Alexander Knuth, Hiroshi Shiku, Helmut Bartsch, Michihiko Kuwano, Kunitada Shimotohno, William T. Beck, Akira Matsuda, Tomoyuki Shirai, Maartin C. Bosland, Kohei Miyazono, Robert H. Shoemaker, Yao-Tseng Chen, Noriyuki Moriyama, Rashmi Sinha, Tommaso A. Dragani, Kei Nakachi, Saburo Sone, Keigo Endo, Hitoshi Nakagama, Eric Stanbridge, Soldano Ferrone Eiichi Nakayama, Yoshikazu Sugimoto, Michael M. Gottesman, Yoshiro Niitsu, Kazuo Tajima, Parry Guilford, Takashi Nishimura, Takashi Takahashi, Nobuyuki Hamajima, Tetsuo Noda, Yoshimi Takai, Curtis C. Harris, Hiroshi Ohshima, Masaru Taniguchi, Kiyohiko Hatake, Hiroyuki Osada, Tadatsugu Taniguchi, Carl-Henrik Heldin, Pier Paolo Pandolfi, Masae Tatematsu, Toshio Hirano, Jae-Gahb Park, Yoichi Taya, Masahiro Hiraoka, Manuel Perucho, Snorri S. Thorgeirsson, Chung-cheng Hsieh, Roger Reddel, Shoichiro Tsugane, Kay Huebner, Nicolas Restifo, Yoshimasa Uehara, Kohzoh Imai, Anita B. Roberts, Kazuo Umezawa, Johji Inazawa, Jeffery S. Rubin, Keiji Wakabayashi, Fuyuki Ishikawa, Nagahiro Saijo, Paul Workman, Kyogo Itoh, Izumu Saito, Yasushi Yamazoe, David H. Johnson, Michiie Sakamoto, Takao Yamori, Tadao Kakizoe, Jacques Samarut, Wataru Yasui, Reiji Kannagi, Takehiko Sasazuki, Jun Yokota, Yutaka Kawakami, Hideyuki Saya, Jun Yoshida, Elliott Kieff, Motoharu Seiki, Teruhiko Yoshida, Akira Kikuchi, Manuel Serrano, Stuart H. Yuspa
|
